VTE Flashcards
Unfractionated Heparin Abbreviation
UFH
Unfractionated Heparin Dosing
Weight based: 80 units/kg IV bolus, 18 units/kg/hr infusion
Unfractionated Heparin Side Effects
Major bleeding Osteoporosis (if long term) Hypersensitivity HIT HAT
Unfractionated Heparin Monitoring
aPTT: Baseline, 6 hours after dose or dose change (x24h), daily after 1st day
Platelet: QOD until day 14
Enoxaparin Brand
Lovenox
Enoxaparin Dosing
Prophylaxis: 30mg SQ q12h OR 40mg SQ daily
Treatment (actual body weight): 1mg/kg SQ q12h OR 1.5mg/kg SQ daily
If CrCl is less than 30ml/min:
Prophylaxis: 30mg SQ daily
Treatment: 1mg/kg SQ daily
Enoxaparin Side Effects
Black box warning: Do NOT use with neural anesthesia/spinal puncture
Bleeding
Thrombocytopenia (less than UFH)
Delayed HS skin reactions
Enoxaparin Monitoring
If CrCl less than 30mL/min (severe kidney failure), children, obesity, long courses, pregnancy, monitor anti-Xa level 4-6h post.
Dalteparin Brand
Fragmin
Dalteparin Dosing
Prophylaxis: 2500-5000 IU SQ daily
Treatment: 200 IU/kg SQ daily (MAX 18000 IU)
Dalteparin Side Effects
Black box warning: Do NOT use with neural anesthesia/spinal puncture
Bleeding
Thrombocytopenia (less than UFH)
Delayed HS skin reactions
Dalteparin Monitoring
If CrCl less than 30mL/min (severe kidney failure), children, obesity, long courses, pregnancy, monitor anti-Xa level 4-6h post.
Tinzaparin Brand
Innohep
Tinzaparin Dosing
Treatment: 175 anti-Xa IU/kg SQ daily
Tinzaparin Side Effects
Black box warning: Do NOT use with neural anesthesia/spinal puncture
Bleeding
Thrombocytopenia (less than UFH)
Delayed HS skin reactions
Tinzaparin Monitoring
If CrCl less than 30mL/min (severe kidney failure), children, obesity, long courses, pregnancy, monitor anti-Xa level 4-6h post.
Fondaparinux Brand
Arixtra
Fondaparinux Dosing
Prophylaxis: 2.5mg SQ daily (not for less than 50 kg or CrCl less than 30ml/min) Treatment: Less than 50: 5mg SQ daily 50-100kg: 7.5mg SQ daily Greater than 100kg: 10mg SQ daily
Fondaparinux Side Effects
Bleeding
Fondaparinux Monitoring
Can monitor anti-Xa levels, but no routine monitoring
Rivaroxaban Brand
Xarelto
Rivaroxaban Dosing
DVT prophylaxis: 10mg PO daily 12-35 days
DVT/PE treatment: 15mg PO BID x3 weeks, then 20mg daily
NV Atrial fibrillation:
20mg PO daily
Rivaroxaban Side Effects
Bleeding
Black box warning: spinal/epidural hematoma and premature D/C increases risk thrombotic event
Rivaroxaban Monitoring
Caution with CYP3A4/P-gp
Edoxaban Brand
Savaysa
Edoxaban Dosing
DVT/PE treatment (after 5-10 days parenteral therapy): 60mg PO daily if CrCl is greater than 50 mL/min
30mg PO daily if CrCl 15-50 mL/min, body weight less than or equal to 60kg
NV atrial fibrillation:
60mg PO QD if CrCl 50-95 mL/min
30mg PO QD if CrCl 15-50 mL/min
Edoxaban Side Effects
Bleeding
Black box warning: spinal/epidural hematomas, premature discontinuation increases risk thrombotic event
Less efficacy in NVAF patient CrCl is greater than 95 mL/min
Edoxaban Monitoring
Caution with CYP3A4/P-gp
Apixaban Brand
Eliquis
Apixaban Dosing
Pregnancy Class B! DVT prophylaxis: 2.5mg PO BID DVT/PE treatment: 10mg PO BID x7 days, then 5mg BID x6 months (2.5 after) NV atrial fibrillation: 5mg PO BID OR 2.5mg PO BID if 2 of: 1) age ≥ 80 years 2) weight ≤ 60kg 3) SCr ≥ 1.5mg/dL OR dialysis + age ≥ 80 years OR weight ≤ 60kg
Apixaban Side Effects
Bleeding
Black box warning: spinal/epidural hematomas, premature discontinuation increases risk thrombotic event
Apixaban Monitoring
Caution with CYP3A4/P-gp
Lepirudin Brand
N/A
Lepirudin Dosing
HIT: 0.15 mg/kg/h
Lepirudin Side Effects
Bleeding
Lepirudin Monitoring
Goal aPTT 1.5-2.5
Reduce dose if CrCl less than 60 ml/min
Bivalirudin Brand
Angiomax
Bivalirudin Dosing
HIT or UFH alternative during PCI: 0.7 mg/kg bolus + 1.75 mg/kg/h infusion
Bivalirudin Side Effects
Bleeding
Bivalirudin Monitoring
None
Argatroban Brand
N/A
Argatroban Dosing
HIT: 2 mcg/kg/min OR 0.5 mcg/kg/min if hepatic insufficiency
Argatroban Side Effects
Bleeding
Argatroban Monitoring
Elevates INR falsely; overlap with warfarin until INR ≥4
Dabigatran Brand
Pradaxa
Dabigatran Dosing
DVT/PE treatment after 5-10 days parenteral anticoag: 150mg PO BID for CrCl ≥30 mL/min
NV atrial fibrillation:
150mg PO BID if CrCl greater than 30 mL/min
75mg PO BID if 15-30 mL/min
Dabigatran Side Effects
Dyspepsia
Bleeding
Dabigatran Monitoring
Recommend alternate greater than 75yo
Keep in manufacturer’s bottle
tPA, Alteplase Brand
Activase
tPA, Alteplase Dosing
10mg IV bolus + 90mg infusion over 2 hours
Most commonly for PE
tPA, Alteplase Side Effects
Bleeding
tPA, Alteplase Monitoring
None
Reteplase Brand
Retevase
Reteplase Dosing
10 units IV over 2 minutes + second dose in 30 mins
For ACS only
Reteplase Side Effects
Bleeding
Reteplase Monitoring
None
Tenecteplase Brand
Tnkase
Tenecteplase Dosing
30mg + 5mg/10kg over 60kg up to 50mg as IV bolus
For ACS only
Tenecteplase Side Effects
Bleeding
Tenecteplase Monitoring
None
Urokinase Brand
Abbokinase
Urokinase Dosing
VTE treatment: 4400 units/kg bolus over 10 minutes + 4400 units/kg/hour for 12 hours
Urokinase Side Effects
Bleeding
Urokinase Monitoring
None
Warfarin Brand
Coumadin, Jantoven
Warfarin Dosing
Starting dose: 5 mg PO QD
Available as 1, 2, 2.5, 3, 4, 5, 6, 7.5, and 10mg tablets
Warfarin Side Effects
Bleeding
Pregnancy Class X
Warfarin Monitoring
CYP2C9, 3A4, 2C19, 1A2 interactions
Goal INR 2.0 – 3.0
*mechanical mitral/caged ball/high risk artificial valve
goal INR 2.5 - 3.5